| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Ceramide glucosyltransferase |
|---|
| Ligand | BDBM50406122 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2266215 |
|---|
| IC50 | 7400±n/a nM |
|---|
| Citation |  Roecker, AJ; Schirripa, KM; Loughran, HM; Tong, L; Liang, T; Fillgrove, KL; Kuo, Y; Bleasby, K; Collier, H; Altman, MD; Ford, MC; Drolet, RE; Cosden, M; Jinn, S; Hatcher, NG; Yao, L; Kandebo, M; Vardigan, JD; Flick, RB; Liu, X; Minnick, C; Price, LA; Watt, ML; Lemaire, W; Burlein, C; Adam, GC; Austin, LA; Marcus, JN; Smith, SM; Fraley, ME Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's Disease. ACS Med Chem Lett14:146-155 (2023) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Ceramide glucosyltransferase |
|---|
| Name: | Ceramide glucosyltransferase |
|---|
| Synonyms: | CEGT_HUMAN | GCS | GLCT-1 | Glucosylceramide synthase | UDP-glucose ceramide glucosyltransferase | UDP-glucose:N-acylsphingosine D-glucosyltransferase | UGCG |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 44859.25 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1435474 |
|---|
| Residue: | 394 |
|---|
| Sequence: | MALLDLALEGMAVFGFVLFLVLWLMHFMAIIYTRLHLNKKATDKQPYSKLPGVSLLKPLK
GVDPNLINNLETFFELDYPKYEVLLCVQDHDDPAIDVCKKLLGKYPNVDARLFIGGKKVG
INPKINNLMPGYEVAKYDLIWICDSGIRVIPDTLTDMVNQMTEKVGLVHGLPYVADRQGF
AATLEQVYFGTSHPRYYISANVTGFKCVTGMSCLMRKDVLDQAGGLIAFAQYIAEDYFMA
KAIADRGWRFAMSTQVAMQNSGSYSISQFQSRMIRWTKLRINMLPATIICEPISECFVAS
LIIGWAAHHVFRWDIMVFFMCHCLAWFIFDYIQLRGVQGGTLCFSKLDYAVAWFIRESMT
IYIFLSALWDPTISWRTGRYRLRCGGTAEEILDV
|
|
|
|---|
| BDBM50406122 |
|---|
| n/a |
|---|
| Name | BDBM50406122 |
|---|
| Synonyms: | CHEMBL5286114 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C21H28N4O3 |
|---|
| Mol. Mass. | 384.472 |
|---|
| SMILES | CCN1CCCN(CC1)C(=O)c1nn(c2CCOCc12)-c1ccc(OC)cc1 |
|---|
| Structure | 
|
|---|
Search and Browse
